Announcing: The 2012 Brinker Awards for Scientific Distinction Winners
We are thrilled to announce today that an American and an Israeli scientist will receive our organization’s highest scientific honor: the 2012 Susan G. Komen for the Cure® Brinker Awards for Scientific Distinction in Basic Science and Clinical Research.
American clinician-scientist Hyman B. Muss, M.D. and Israeli researcher Yosef Yarden, Ph.D., will be honored at the San Antonio Breast Cancer Symposium in December.
Muss is receiving the Brinker Award for Scientific Distinction in Clinical Research for work focused on older breast cancer patients, paving the way to state-of-the art treatments and a better standard of care and quality of life for senior women with breast cancer. Muss is director of the Geriatric Oncology Program at University of North Carolina Lineberger Comprehensive Cancer Center in Chapel Hill.
The Brinker Award for Scientific Distinction in Basic Science honors Yarden’s work to advance our understanding of the biology of breast cancer and identify new targets for cancer drugs. Yarden is the Harold and Zelda Goldenberg Professor of Molecular Cell Biology at the Weizmann Institute of Science in Rehovot, Israel.
As the largest nonprofit funder of breast cancer research (outside of the federal government), Susan G. Komen for the Cure currently funds more than 500 research projects totaling $300 million all around the world. Our focus is on preventive strategies and treatments along the entire “continuum of care” – from prevention to early detection to treatments for metastatic and aggressive forms of the disease.
Since 1982, we’ve invested more than three-quarters of a billion dollars to research, touching every major advance in breast cancer treatment. Our 2012 portfolio alone includes 154 grants totaling $58 million.
Komen established the Brinker Awards for Scientific Distinction in 1992 to recognize the groundbreaking work of outstanding researchers and clinicians in breast cancer.
Click here to read the official release, including comments from Komen’s Chief Scientific Advisors, Eric P. Winer, M.D., and George W. Sledge, Jr., M.D., and more information on the incredible work of Dr. Muss and Prof. Yarden.
About the author
Nancy G. Brinker promised her dying sister, Susan G. Komen, she would do everything in her power to end breast cancer forever. In 1982, that promise became Susan G. Komen for the Cure and launched the global breast cancer movement. Today, Komen for the Cure is the world’s largest grassroots network of breast cancer survivors and activists fighting to save lives, empower people, ensure quality care for all and energize science to find the cures. Thanks to events like the Komen Race for the Cure®, we have invested more than $1.9 billion to fulfill our promise, becoming the largest source of nonprofit funds dedicated to the fight against breast cancer in the world.
Share this post